Product Review

Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal tract. Clinical trials have shown that GR-1 and RC-14:

• Help to maintain or restore healthy vaginal flora that are important in maintaining vaginal health

• Support the health of the urinary tract fem-dophilus is manufactured under pharmaceutical GMP conditions insuring potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine. Fem-dophilus is manufactured under pharmaceutical GMP conditions insuring potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine. The cool ship process creates a custom fulfillment pathway so that probiotic products are kept refrigerated up until the point they are shipped. The products are packed in a unique cool ship box that utilizes insulation made with sustainable cotton fiber and cooled with reusable ice packs. The products are then fulfilled with either next day or second day shipping. This process delivers probiotics that have been kept cool and, in most cases, not exposed to prolonged extreme heat, supporting the highest levels of product potency.